Successful treatment with ganciclovir for cytomegalovirus duodenitis following allogenic bone marrow transplantation

Korean J Intern Med. 1999 Jan;14(1):91-4. doi: 10.3904/kjim.1999.14.1.91.

Abstract

Cytomegalovirus(CMV) disease is a major cause of morbidity and mortality in immunocompromised patients. CMV enteritis should be considered when nausea and vomiting continue 3 to 4 weeks after bone marrow transplantation(BMT). The treatment of CMV enteritis is not well established. We report a CMV duodenitis patient following allogenic bone marrow transplantation. The patient had prolonged nausea and vomiting for 5 weeks after bone marrow transplantation and CMV duodenitis was diagnosed by the gastroduodenoscopic mucosal biopsy which showed cytomegalic cells. Ganciclovir treatment for 3 weeks resulted in the resolution of symptoms and promoted healing of the lesion. The patient was free of CMV infection until 288 days after allogenic BMT without maintenance ganciclovir treatment.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Bone Marrow Transplantation / adverse effects
  • Cytomegalovirus Infections / diagnosis
  • Cytomegalovirus Infections / drug therapy*
  • Cytomegalovirus Infections / etiology
  • Duodenitis / diagnosis
  • Duodenitis / drug therapy*
  • Duodenitis / etiology
  • Ganciclovir / therapeutic use*
  • Humans
  • Male
  • Transplantation, Homologous

Substances

  • Antiviral Agents
  • Ganciclovir